
Dean Assimos
Professor and Chair, Department of Urology · University of Alabama Hospital
Credentials: · · ·
History
PresentDepartment of Urology · University of Alabama Hospital


- 1977–1982
Urology

Research
The Journal of Urology · 2016 · First of 13 authors · 904 citations
Kidney stones: a global picture of prevalence, incidence, and associated risk factors
Reviews in urology · 2010 · Last of 3 authors · 869 citations
Medical management of kidney stones: AUA guideline
The Journal of Urology · 2014 · 830 citations

36 papers · 9 as a resident
- BM
19 papers · 13 as a resident

18 papers

15 papers

14 papers · 7 as a fellow
- DM
13 papers

13 papers · 13 as a resident

12 papers
Grants
- 2023–2028
Deep South KUH Premier Research and Inter-Disciplinary Mentored Education (PRIME)
National Institute of Diabetes and Digestive and Kidney Diseases · U2C
PI · $2.3M · University of Alabama at Birmingham
- 2021–2025
Effect of Weight Loss on Urinary Oxalate Excretion in Obese Calcium Oxalate Kidney Stone Formers
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $943.8K · University of Alabama at Birmingham
- 2018–2023
The Influence of Obesity on Oxalate Metabolism and Handling in Calcium Oxalate Stone Formers
National Institute of Diabetes and Digestive and Kidney Diseases · P20
Contact PI · $1.2M · University of Alabama at Birmingham
- 2002–2013
Dietary Oxalate and Kidney Stone Formation
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.4M · Wake Forest University Health Sciences
Clinical trials
- 2021–2026
Effect of Weight Loss on Urinary Oxalate Excretion in Obese Calcium Oxalate Kidney Stone Formers
Principal investigator · Active not recruiting
University of Alabama at Birmingham
- 2021–2027
Influence of Obesity on Oxalate Metabolism and Handling in Calcium Oxalate Stone Formers
Principal investigator · Active not recruiting
University of Alabama at Birmingham
- 2019–2026
Influence of Obesity on Endogenous Oxalate Synthesis
Principal investigator · Active not recruiting
University of Alabama at Birmingham
- 2017–2018
Bucillamine Phase 2 Trial in Patients With Cystinuria
Site PI · Unknown · Phase 2
Revive Therapeutics, Ltd.



